Stargardt’s Disease and other inherited macular dystrophies typically start affecting central vision at a young age, gradually making everyday tasks like reading and recognizing faces more difficult, while peripheral vision generally holds steady for a longer stretch of time. India has become a well-known choice for **Stargardt’s or Macular Dystrophy treatment for patients from Mexico**, though a complete cure for this inherited macular condition remains an ongoing pursuit within global medicine.
Within a wider Stargardt’s / Macular Dystrophy treatment approach, stem cell-based therapy is regarded as an evolving area of interest for patients whose macular cells are progressively affected. This treatment path is explored for its potential to support the macula’s remaining functional cells, giving young patients and their families an additional avenue to discuss alongside standard low-vision support.
As part of a structured Stargardt’s / Macular Dystrophy treatment plan, Mesenchymal stem cell injections through the Retro-bulbar route have become a widely adopted method, typically completed within one or two sessions. This approach has shown a favorable track record supporting the regenerative response of macular and photoreceptor cells, with relevance spanning macular cells, photoreceptor cells, and the retinal pigment epithelium.
Families in Mexico navigating a Stargardt’s diagnosis are welcome to connect with the Eye Stem Cell Center, which brings more than 12 years of focused experience with inherited macular conditions. Our specialists carefully review fundus autofluorescence imaging, OCT, and ERG reports before advising any family on the way forward.
Eye Stem Cell Center is one of the most trusted providers of Stargardt’s or Macular Dystrophy treatment in Mexico.

